blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3897700

EP3897700 - PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  24.09.2021
Database last updated on 24.08.2024
FormerThe international publication has been made
Status updated on  02.07.2020
Most recent event   Tooltip16.02.2024New entry: Decision on request for further processing 
Applicant(s)For all designated states
Immune Design Corp.
1616 Eastlake Ave. E.
Suite 310
Seattle, WA 98102 / US
[2021/43]
Inventor(s)01 / BERGLUND, Peter Lars Aksel
1616 Eastlake Avenue E, Suite 310
Seattle, Washington 98102 / US
02 / ALBERSHARDT, Tinglan Tina
7725 Woods Estate Lane NE
Olympia, Washington 98506 / US
03 / TER MEULEN, Jan Henrik
3842 W. Mercer Way
Mercer Island, Washington 98040 / US
04 / LELEUX, Jardin Alexandra
1616 Eastlake Avenue E, Suite 310
Seattle, Washington 98102 / US
 [2021/43]
Representative(s)Merck Sharp & Dohme LLC
120 Moorgate
London EC2M 6UR / GB
[N/P]
Former [2021/43]Böhles, Elena
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
Application number, filing date19898589.716.12.2019
[2021/43]
WO2019US66444
Priority number, dateUS201862780665P17.12.2018         Original published format: US 201862780665 P
[2021/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020131656
Date:25.06.2020
Language:EN
[2020/26]
Type: A1 Application with search report 
No.:EP3897700
Date:27.10.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 25.06.2020 takes the place of the publication of the European patent application.
[2021/43]
Search report(s)International search report - published on:US25.06.2020
(Supplementary) European search report - dispatched on:EP14.04.2023
ClassificationIPC:A61K39/00, A61K39/39, C07K14/54, C12N15/86
[2023/19]
CPC:
A61P35/00 (EP); A61K39/0011 (EP,US); A61K39/39 (EP,US);
A61K45/06 (US); C07K14/5434 (EP); C12N15/86 (EP);
A61K2039/53 (EP); A61K2039/55538 (EP,US); A61K2039/585 (EP);
C12N2770/36122 (EP); C12N2770/36143 (EP) (-)
Former IPC [2021/43]A61K39/00, A61K39/39
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/43]
TitleGerman:PATHOGENASSOZIIERTE MOLEKULARE MUSTERMOLEKÜLE UND RNA-IMMUNOGENE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DER ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KREBS[2021/43]
English:PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER[2021/43]
French:MOLÉCULES À MOTIFS MOLÉCULAIRES ASSOCIÉS À DES AGENTS PATHOGÈNES ET COMPOSITIONS IMMUNOGÈNES D'ARN ET MÉTHODES D'UTILISATION DES COMPOSITIONS POUR LE TRAITEMENT DU CANCER[2021/43]
Entry into regional phase19.07.2021National basic fee paid 
19.07.2021Search fee paid 
19.07.2021Designation fee(s) paid 
19.07.2021Examination fee paid 
Examination procedure19.07.2021Examination requested  [2021/43]
07.12.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
06.02.2024Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
06.02.2024Request for further processing filed
06.02.2024Full payment received (date of receipt of payment)
Request granted
15.02.2024Decision despatched
Fees paidRenewal fee
16.12.2021Renewal fee patent year 03
09.12.2022Renewal fee patent year 04
12.12.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2009046739  (CUREVAC GMBH [DE], et al);
 [XI]EP3374374  (IMMUNE DESIGN CORP [US]);
International search[Y]US6617135  (GILLIES STEPHEN D [US], et al);
 [Y]US2006226667  (LEAVERTON JOHN [US]);
 [Y]US2008213318  (CLEMENTS DAVID E [US], et al);
 [Y]WO2016016401  (BOEHRINGER INGELHEIM VETMED [DE]);
 [Y]US2018169226  (REED STEVEN G [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.